Worth reading
69In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
16th Stock Acquisition Rights issued through a private placement (with Exercise Price Adjustment Clause)
Intended allottee
EVO FUND
発行済株式総数
Exercise ratio under the exercise restrictions: —% (shares delivered in June 2026: — shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥416 (on each business day during the relevant month). Details of the adjustment clause are not disclosed in this document.
Number of Stock Acquisition Rights
Total issued: 17,000; unexercised at the end of the month preceding the relevant month: 2,100; unexercised at the end of the relevant month: 2,100
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Timing 1 August 2025 / Type Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | 16th Stock Acquisition Rights issued through a private placement (with Exercise Price Adjustment Clause) |
| Intended allottee | EVO FUND |
| Dilution Rate | Exercise ratio under the exercise restrictions: —% (shares delivered in June 2026: — shares) |
| Total number of issued shares | 8,383,200 shares (as of 31 May 2026) → Equivalent to 8,383,200 shares (no increase from exercises)（0％） |
| Exercise price | ¥416 (on each business day during the relevant month). Details of the adjustment clause are not disclosed in this document. |
| Number of Stock Acquisition Rights | Total issued: 17,000; unexercised at the end of the month preceding the relevant month: 2,100; unexercised at the end of the relevant month: 2,100 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 1 August 2025 / Type Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) / Amount Not disclosed |
Items this document does not state (20)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company reported the exercise status. No reason was given for the absence of exercises.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.